Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Farinati

Showing results (1-10 of 253) with videos related to

Pageof 26
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 4, 2011
Digestive oncology: It's now or neverFabio Farinati
Hepatology (Baltimore, Md.)|March 6, 2013
Risk factors associated with hepatocellular carcinoma in primary biliary cirrhosisAnnarosa Floreani, Fabio Farinati
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 25, 2024
Gastric cancer screening in Western countries: A call to actionFabio Farinati, Filippo Pelizzaro
Cancer Chemotherapy and Pharmacology|November 11, 2011
Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver functionFabio Farinati, Anna Giacomin, Veronica Vanin
Journal of Hepatology|April 12, 2002
Apoptosis in alcoholic hepatitisFabio Farinati, Romilda Cardin, Michelangelo Fiorentino
Biomedicines|May 16, 2023
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or ResistanceFilippo Pelizzaro, Fabio Farinati, Franco Trevisani
The American Journal of Gastroenterology|July 4, 2013
Adequate interval for hepatocellular carcinoma surveillanceEdoardo G Giannini, Fabio Farinati, Franco Trevisani
Hepatology (Baltimore, Md.)|June 29, 2011
Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the deadEdoardo G Giannini, Fabio Farinati, Franco Trevisani
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 12, 2017
HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: A "true-or-false game"Francesco Paolo Russo, Savino Bruno, Fabio Farinati
Hepatology (Baltimore, Md.)|February 29, 2008
TGF-beta and hepatocellular carcinomaMarina Bortolami, Romilda Cardin, Andromachi Kotsafti, et al.
Pageof 26

Showing results (1-10 of 253) with videos related to

Sort By:
Pageof 26
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 4, 2011
Digestive oncology: It's now or neverFabio Farinati
Hepatology (Baltimore, Md.)|March 6, 2013
Risk factors associated with hepatocellular carcinoma in primary biliary cirrhosisAnnarosa Floreani, Fabio Farinati
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 25, 2024
Gastric cancer screening in Western countries: A call to actionFabio Farinati, Filippo Pelizzaro
Cancer Chemotherapy and Pharmacology|November 11, 2011
Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver functionFabio Farinati, Anna Giacomin, Veronica Vanin
Journal of Hepatology|April 12, 2002
Apoptosis in alcoholic hepatitisFabio Farinati, Romilda Cardin, Michelangelo Fiorentino
Biomedicines|May 16, 2023
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or ResistanceFilippo Pelizzaro, Fabio Farinati, Franco Trevisani
The American Journal of Gastroenterology|July 4, 2013
Adequate interval for hepatocellular carcinoma surveillanceEdoardo G Giannini, Fabio Farinati, Franco Trevisani
Hepatology (Baltimore, Md.)|June 29, 2011
Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the deadEdoardo G Giannini, Fabio Farinati, Franco Trevisani
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 12, 2017
HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: A "true-or-false game"Francesco Paolo Russo, Savino Bruno, Fabio Farinati
Hepatology (Baltimore, Md.)|February 29, 2008
TGF-beta and hepatocellular carcinomaMarina Bortolami, Romilda Cardin, Andromachi Kotsafti, et al.
Pageof 26